Evidence map›Paper›PMID 38782403›Full record

ArticleAnalytical chemistry2024

Comparative Metabolomics and Microbiome Analysis of Ethanol versus OMNImet/gene•GUT Fecal Stabilization.

Heidi Isokääntä, Lucas Pinto da Silva, Naama Karu, Teemu Kallonen, Anna-Katariina Aatsinki, Thomas Hankemeier, Leyla Schimmel, Edgar Diaz, Tuulia Hyötyläinen, Pieter C Dorrestein and 5 more

Erratum issuedAbstract readComparative Study
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Heidi IsokääntäResearch Center for Infections and Immunity, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland.
Lucas Pinto da SilvaTurku Bioscience Centre, University of Turku, Tykistönkatu 6A, 20520 Turku, Finland.
Naama KaruMetabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden 2333 CC, The Netherlands.
Teemu KallonenDepartment of Clinical Microbiology, Laboratory Division, Turku University Hospital, Kiinamyllynkatu 10 D, 20520 Turku, Finland.
Anna-Katariina AatsinkiCentre for Population Health Research, University of Turku, Kiinamyllynkatu 10A, 20520 Turku, Finland.
Thomas HankemeierMetabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden 2333 CC, The Netherlands.
Leyla SchimmelDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina 27708-0187, United States.
Edgar DiazDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina 27708-0187, United States.
Tuulia HyötyläinenSchool of Science and Technology, Örebro University, 70281 Örebro, Sweden.ORCID 0000-0002-1389-8302
Pieter C DorresteinCenter for Microbiome Innovation, University of California, San Diego, La Jolla, California 92093-6607, United States.ORCID 0000-0002-3003-1030
Rob KnightCenter for Microbiome Innovation, University of California, San Diego, La Jolla, California 92093-6607, United States.
Matej OrešičTurku Bioscience Centre, University of Turku, Tykistönkatu 6A, 20520 Turku, Finland.
Rima Kaddurah-DaoukDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina 27708-0187, United States.
Alex M DickensTurku Bioscience Centre, University of Turku, Tykistönkatu 6A, 20520 Turku, Finland.ORCID 0000-0002-3178-8449
Santosh LamichhaneTurku Bioscience Centre, University of Turku, Tykistönkatu 6A, 20520 Turku, Finland.ORCID 0000-0002-9292-3595

Funding

Project 4 - Mechanistic studies on the role of the gut microbiome in models for Alzheimer's diseaseU19AG063744 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ROB KNIGHT, Rima F Kaddurah-Daouk · 2019 to 2026
$54.1M
NIA NIH HHS U19 AG063744
6 · The paper itself

Abstract

Metabolites from feces provide important insights into the functionality of the gut microbiome. As immediate freezing is not always feasible in gut microbiome studies, there is a need for sampling protocols that provide the stability of the fecal metabolome and microbiome at room temperature (RT). Here, we investigated the stability of various metabolites and the microbiome (16S rRNA) in feces collected in 95% ethanol (EtOH) and commercially available sample collection kits with specific preservatives OMNImet•GUT/OMNIgene•GUT. To simulate field-collection scenarios, the samples were stored at different temperatures at varying durations (24 h + 4 °C, 24 h RT, 36 h RT, 48 h RT, and 7 days RT) and compared to aliquots immediately frozen at -80 °C. We applied several targeted and untargeted metabolomics platforms to measure lipids, polar metabolites, endocannabinoids, short-chain fatty acids (SCFAs), and bile acids (BAs). We found that SCFAs in the nonstabilized samples increased over time, while a stable profile was recorded in sample aliquots stored in 95% EtOH and OMNImet•GUT. When comparing the metabolite levels between aliquots stored at room temperature and at +4 °C, we detected several changes in microbial metabolites, including multiple BAs and SCFAs. Taken together, we found that storing samples at RT and stabilizing them in 95% EtOH yielded metabolomic results comparable to those from flash freezing. We also found that the overall composition of the microbiome did not vary significantly between different storage types. However, notable differences were observed in the α diversity. Altogether, the stability of the metabolome and microbiome in 95% EtOH provided results similar to those of the validated commercial collection kits OMNImet•GUT and OMNIgene•GUT, respectively.

Indexed as

EthanolFecesGastrointestinal MicrobiomeMetabolomicsSpecimen HandlingHumansRNA, Ribosomal, 16STemperatureEthanolRNA, Ribosomal, 16S

Identifiers

PMID38782403
PMCPMC11154662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.